shereen elazzazy
Hamad Medical Corporation
Doha, Qatar
Review Editor
Hematologic Malignancies
Editors
- Frontiers in Oncology
- Hematologic Malignancies
- Editorial board
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Review Editors
rashid elhag
Florida Agricultural and Mechanical University
Tallahassee, United States
Review Editor
Hematologic Malignancies
hany elmariah
Moffitt Cancer Center
Tampa, United States
Review Editor
Hematologic Malignancies
ashkan emadi
University of Maryland Medical Center
Baltimore, United States
Review Editor
Hematologic Malignancies
herbert eradat
University of California, Los Angeles
Los Angeles, United States
Review Editor
Hematologic Malignancies
xing fan
National Institutes of Health (NIH)
Bethesda, United States
Review Editor
Hematologic Malignancies
francesca farina
San Raffaele Hospital (IRCCS)
Milan, Italy
Review Editor
Hematologic Malignancies
timothy farren
Barts Health NHS Trust
London, United Kingdom
Review Editor
Hematologic Malignancies
mehdi fazel najafabadi
Oklahoma Medical Research Foundation
Oklahoma City, United States
Review Editor
Hematologic Malignancies
yuri fedoriw
University of North Carolina at Chapel Hill
Chapel Hill, United States
Review Editor
Hematologic Malignancies
concettina fenga
University of Messina
Messina, Italy
Review Editor
Hematologic Malignancies
sandra v fernandez
Fox Chase Cancer Center
Philadelphia, United States
Review Editor
Hematologic Malignancies
teresa de souza fernandez
National Cancer Institute (INCA)
Rio de Janeiro, Brazil
Review Editor
Hematologic Malignancies
rodrigo fernando
Gilead (United States)
Foster City, United States
Review Editor
Hematologic Malignancies
felicetto ferrara
Hospital Antonio Cardarelli
Naples, Italy
Review Editor
Hematologic Malignancies
gerardo ferrer
Josep Carreras Leukaemia Research Institute (IJC)
Badalona, Spain
Review Editor
Hematologic Malignancies